nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—Vasculitis necrotising—Leflunomide—systemic scleroderma	0.0464	0.0464	CcSEcCtD
Polythiazide—Gastric irritation—Captopril—systemic scleroderma	0.0304	0.0304	CcSEcCtD
Polythiazide—Angiitis necrotising—Prednisone—systemic scleroderma	0.0272	0.0272	CcSEcCtD
Polythiazide—Vasculitis necrotising—Prednisone—systemic scleroderma	0.0237	0.0237	CcSEcCtD
Polythiazide—Epigastric discomfort—Captopril—systemic scleroderma	0.0224	0.0224	CcSEcCtD
Polythiazide—Aplastic anaemia—Pentoxifylline—systemic scleroderma	0.0146	0.0146	CcSEcCtD
Polythiazide—Jaundice cholestatic—Captopril—systemic scleroderma	0.0134	0.0134	CcSEcCtD
Polythiazide—Gastric irritation—Prednisone—systemic scleroderma	0.0128	0.0128	CcSEcCtD
Polythiazide—Vascular purpura—Pentoxifylline—systemic scleroderma	0.0126	0.0126	CcSEcCtD
Polythiazide—Vasculitis—Captopril—systemic scleroderma	0.0121	0.0121	CcSEcCtD
Polythiazide—Purpura—Pentoxifylline—systemic scleroderma	0.0117	0.0117	CcSEcCtD
Polythiazide—Jaundice cholestatic—Azathioprine—systemic scleroderma	0.0117	0.0117	CcSEcCtD
Polythiazide—Jaundice cholestatic—Mycophenolic acid—systemic scleroderma	0.0106	0.0106	CcSEcCtD
Polythiazide—Vasculitis—Azathioprine—systemic scleroderma	0.0105	0.0105	CcSEcCtD
Polythiazide—Hyperuricaemia—Mycophenolic acid—systemic scleroderma	0.01	0.01	CcSEcCtD
Polythiazide—Vasculitis—Leflunomide—systemic scleroderma	0.00996	0.00996	CcSEcCtD
Polythiazide—Photosensitivity—Captopril—systemic scleroderma	0.00975	0.00975	CcSEcCtD
Polythiazide—Aplastic anaemia—Azathioprine—systemic scleroderma	0.00966	0.00966	CcSEcCtD
Polythiazide—Jaundice cholestatic—Lisinopril—systemic scleroderma	0.00951	0.00951	CcSEcCtD
Polythiazide—Blood uric acid increased—Mycophenolic acid—systemic scleroderma	0.00944	0.00944	CcSEcCtD
Polythiazide—Epigastric discomfort—Prednisone—systemic scleroderma	0.00943	0.00943	CcSEcCtD
Polythiazide—Vasculitis—Lisinopril—systemic scleroderma	0.00856	0.00856	CcSEcCtD
Polythiazide—Jaundice—Pentoxifylline—systemic scleroderma	0.00849	0.00849	CcSEcCtD
Polythiazide—Jaundice cholestatic—Mycophenolate mofetil—systemic scleroderma	0.00833	0.00833	CcSEcCtD
Polythiazide—Hyperuricaemia—Mycophenolate mofetil—systemic scleroderma	0.00789	0.00789	CcSEcCtD
Polythiazide—Orthostatic hypotension—Captopril—systemic scleroderma	0.00782	0.00782	CcSEcCtD
Polythiazide—Blood uric acid increased—Mycophenolate mofetil—systemic scleroderma	0.00745	0.00745	CcSEcCtD
Polythiazide—Pancreatitis—Captopril—systemic scleroderma	0.00726	0.00726	CcSEcCtD
Polythiazide—Photosensitivity—Lisinopril—systemic scleroderma	0.00691	0.00691	CcSEcCtD
Polythiazide—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00687	0.00687	CcSEcCtD
Polythiazide—Photosensitivity reaction—Captopril—systemic scleroderma	0.00675	0.00675	CcSEcCtD
Polythiazide—Muscle spasms—Pentoxifylline—systemic scleroderma	0.00654	0.00654	CcSEcCtD
Polythiazide—Jaundice—Captopril—systemic scleroderma	0.00643	0.00643	CcSEcCtD
Polythiazide—Cramp muscle—Leflunomide—systemic scleroderma	0.00635	0.00635	CcSEcCtD
Polythiazide—Pancreatitis—Azathioprine—systemic scleroderma	0.00633	0.00633	CcSEcCtD
Polythiazide—Agitation—Pentoxifylline—systemic scleroderma	0.00625	0.00625	CcSEcCtD
Polythiazide—Agranulocytosis—Captopril—systemic scleroderma	0.00616	0.00616	CcSEcCtD
Polythiazide—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.00615	0.00615	CcSEcCtD
Polythiazide—Glycosuria—Prednisone—systemic scleroderma	0.00612	0.00612	CcSEcCtD
Polythiazide—Leukopenia—Pentoxifylline—systemic scleroderma	0.00609	0.00609	CcSEcCtD
Polythiazide—Cramp muscle—Mycophenolic acid—systemic scleroderma	0.00606	0.00606	CcSEcCtD
Polythiazide—Pancreatitis—Leflunomide—systemic scleroderma	0.00598	0.00598	CcSEcCtD
Polythiazide—Pancreatitis—Mycophenolic acid—systemic scleroderma	0.0057	0.0057	CcSEcCtD
Polythiazide—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.00554	0.00554	CcSEcCtD
Polythiazide—Hyperglycaemia—Leflunomide—systemic scleroderma	0.0055	0.0055	CcSEcCtD
Polythiazide—Cramp muscle—Lisinopril—systemic scleroderma	0.00546	0.00546	CcSEcCtD
Polythiazide—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00544	0.00544	CcSEcCtD
Polythiazide—Agranulocytosis—Azathioprine—systemic scleroderma	0.00537	0.00537	CcSEcCtD
Polythiazide—Jaundice—Leflunomide—systemic scleroderma	0.0053	0.0053	CcSEcCtD
Polythiazide—Anorexia—Pentoxifylline—systemic scleroderma	0.00529	0.00529	CcSEcCtD
Polythiazide—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.00525	0.00525	CcSEcCtD
Polythiazide—Pancreatitis—Lisinopril—systemic scleroderma	0.00514	0.00514	CcSEcCtD
Polythiazide—Vasculitis—Prednisone—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Polythiazide—Agranulocytosis—Leflunomide—systemic scleroderma	0.00507	0.00507	CcSEcCtD
Polythiazide—Jaundice—Mycophenolic acid—systemic scleroderma	0.00506	0.00506	CcSEcCtD
Polythiazide—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00485	0.00485	CcSEcCtD
Polythiazide—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00484	0.00484	CcSEcCtD
Polythiazide—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00483	0.00483	CcSEcCtD
Polythiazide—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00478	0.00478	CcSEcCtD
Polythiazide—Constipation—Pentoxifylline—systemic scleroderma	0.00475	0.00475	CcSEcCtD
Polythiazide—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00473	0.00473	CcSEcCtD
Polythiazide—Anorexia—Mometasone—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Polythiazide—Jaundice—Lisinopril—systemic scleroderma	0.00455	0.00455	CcSEcCtD
Polythiazide—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	0.0045	0.0045	CcSEcCtD
Polythiazide—Hyperuricaemia—Methotrexate—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Polythiazide—Urticaria—Pentoxifylline—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Polythiazide—Agranulocytosis—Lisinopril—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Polythiazide—Paraesthesia—Mometasone—systemic scleroderma	0.0043	0.0043	CcSEcCtD
Polythiazide—Vasculitis—Methotrexate—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Polythiazide—Blood uric acid increased—Methotrexate—systemic scleroderma	0.00422	0.00422	CcSEcCtD
Polythiazide—Decreased appetite—Mometasone—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Polythiazide—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00414	0.00414	CcSEcCtD
Polythiazide—Thrombocytopenia—Captopril—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Polythiazide—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00409	0.00409	CcSEcCtD
Polythiazide—Muscle spasms—Leflunomide—systemic scleroderma	0.00409	0.00409	CcSEcCtD
Polythiazide—Leukopenia—Azathioprine—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Polythiazide—Vascular purpura—Prednisone—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Polythiazide—Anorexia—Captopril—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Polythiazide—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Polythiazide—Asthenia—Pentoxifylline—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Polythiazide—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Polythiazide—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00389	0.00389	CcSEcCtD
Polythiazide—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Polythiazide—Vertigo—Leflunomide—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Polythiazide—Leukopenia—Leflunomide—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Polythiazide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Polythiazide—Paraesthesia—Captopril—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Polythiazide—Purpura—Prednisone—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Polythiazide—Agitation—Mycophenolic acid—systemic scleroderma	0.00373	0.00373	CcSEcCtD
Polythiazide—Dizziness—Pentoxifylline—systemic scleroderma	0.00367	0.00367	CcSEcCtD
Polythiazide—Decreased appetite—Captopril—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Polythiazide—Vertigo—Mycophenolic acid—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Polythiazide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Polythiazide—Constipation—Captopril—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Polythiazide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Polythiazide—Vomiting—Pentoxifylline—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Polythiazide—Muscle spasms—Lisinopril—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Polythiazide—Rash—Pentoxifylline—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Polythiazide—Dermatitis—Pentoxifylline—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Polythiazide—Headache—Pentoxifylline—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Polythiazide—Asthenia—Mometasone—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Polythiazide—Photosensitivity—Methotrexate—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Polythiazide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Polythiazide—Anorexia—Leflunomide—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Polythiazide—Nausea—Pentoxifylline—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Polythiazide—Vertigo—Lisinopril—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Polythiazide—Diarrhoea—Mometasone—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Polythiazide—Leukopenia—Lisinopril—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Polythiazide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Polythiazide—Anorexia—Mycophenolic acid—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Polythiazide—Paraesthesia—Leflunomide—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Polythiazide—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Polythiazide—Pancreatitis—Prednisone—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Polythiazide—Vomiting—Mometasone—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Polythiazide—Rash—Mometasone—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Polythiazide—Asthenia—Captopril—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Polythiazide—Dermatitis—Mometasone—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Polythiazide—Decreased appetite—Leflunomide—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Polythiazide—Headache—Mometasone—systemic scleroderma	0.003	0.003	CcSEcCtD
Polythiazide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Polythiazide—Constipation—Leflunomide—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Polythiazide—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Polythiazide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Polythiazide—Diarrhoea—Captopril—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Polythiazide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Polythiazide—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Polythiazide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Polythiazide—Nausea—Mometasone—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Polythiazide—Anorexia—Lisinopril—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Polythiazide—Constipation—Mycophenolic acid—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Polythiazide—Hyperglycaemia—Prednisone—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Polythiazide—Dizziness—Captopril—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Polythiazide—Urticaria—Leflunomide—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Polythiazide—Hypersensitivity—Azathioprine—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Polythiazide—Paraesthesia—Lisinopril—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Polythiazide—Vomiting—Captopril—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Polythiazide—Rash—Captopril—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Polythiazide—Dermatitis—Captopril—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Polythiazide—Headache—Captopril—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Polythiazide—Decreased appetite—Lisinopril—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Polythiazide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Polythiazide—Hypersensitivity—Leflunomide—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Polythiazide—Pancreatitis—Methotrexate—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Polythiazide—Constipation—Lisinopril—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Polythiazide—Diarrhoea—Azathioprine—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Polythiazide—Nausea—Captopril—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Polythiazide—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Polythiazide—Asthenia—Leflunomide—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Polythiazide—Dizziness—Azathioprine—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Polythiazide—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Polythiazide—Asthenia—Mycophenolic acid—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Polythiazide—Diarrhoea—Leflunomide—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Polythiazide—Urticaria—Lisinopril—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Polythiazide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Polythiazide—Vomiting—Azathioprine—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Polythiazide—Rash—Azathioprine—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Polythiazide—Dermatitis—Azathioprine—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Polythiazide—Headache—Azathioprine—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Polythiazide—Dizziness—Leflunomide—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Polythiazide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Polythiazide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Polythiazide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Polythiazide—Vomiting—Leflunomide—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Polythiazide—Hypersensitivity—Lisinopril—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Polythiazide—Dizziness—Mycophenolic acid—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Polythiazide—Rash—Leflunomide—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Polythiazide—Dermatitis—Leflunomide—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Polythiazide—Nausea—Azathioprine—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Polythiazide—Headache—Leflunomide—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Polythiazide—Agranulocytosis—Methotrexate—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Polythiazide—Asthenia—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Polythiazide—Vomiting—Mycophenolic acid—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Polythiazide—Rash—Mycophenolic acid—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Polythiazide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Polythiazide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Polythiazide—Headache—Mycophenolic acid—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Polythiazide—Nausea—Leflunomide—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Polythiazide—Diarrhoea—Lisinopril—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Polythiazide—Agitation—Prednisone—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Polythiazide—Dizziness—Lisinopril—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Polythiazide—Nausea—Mycophenolic acid—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Polythiazide—Vertigo—Prednisone—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Polythiazide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Polythiazide—Vomiting—Lisinopril—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Polythiazide—Rash—Lisinopril—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Polythiazide—Dermatitis—Lisinopril—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Polythiazide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Polythiazide—Headache—Lisinopril—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Polythiazide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Polythiazide—Nausea—Lisinopril—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Polythiazide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Polythiazide—Anorexia—Prednisone—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Polythiazide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Polythiazide—Rash—Mycophenolate mofetil—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Polythiazide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Polythiazide—Headache—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Polythiazide—Vertigo—Methotrexate—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Polythiazide—Leukopenia—Methotrexate—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Polythiazide—Paraesthesia—Prednisone—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Polythiazide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Polythiazide—Decreased appetite—Prednisone—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Polythiazide—Constipation—Prednisone—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Polythiazide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Polythiazide—Anorexia—Methotrexate—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Polythiazide—Urticaria—Prednisone—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Polythiazide—Paraesthesia—Methotrexate—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Polythiazide—Hypersensitivity—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Polythiazide—Decreased appetite—Methotrexate—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Polythiazide—Asthenia—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Polythiazide—Diarrhoea—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Polythiazide—Urticaria—Methotrexate—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Polythiazide—Dizziness—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Polythiazide—Vomiting—Prednisone—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Polythiazide—Rash—Prednisone—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Polythiazide—Dermatitis—Prednisone—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Polythiazide—Headache—Prednisone—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Polythiazide—Hypersensitivity—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Polythiazide—Asthenia—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Polythiazide—Nausea—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Polythiazide—Diarrhoea—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Polythiazide—Dizziness—Methotrexate—systemic scleroderma	0.000978	0.000978	CcSEcCtD
Polythiazide—Vomiting—Methotrexate—systemic scleroderma	0.00094	0.00094	CcSEcCtD
Polythiazide—Rash—Methotrexate—systemic scleroderma	0.000933	0.000933	CcSEcCtD
Polythiazide—Dermatitis—Methotrexate—systemic scleroderma	0.000932	0.000932	CcSEcCtD
Polythiazide—Headache—Methotrexate—systemic scleroderma	0.000927	0.000927	CcSEcCtD
Polythiazide—Nausea—Methotrexate—systemic scleroderma	0.000879	0.000879	CcSEcCtD
